ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.52
0.00%
US Tech 100
17,564.00
-0.22%
S&P 500
5,187.67
0.00%
US Dollar vs CAD
1.37256
-0.02%
Bitcoin
60,864.68
-0.54%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/09/20246:11AMPR Newswire (US)7-Eleven Launches Newest Iteration of 'Take It to Eleven' Campaign
05/09/20246:10AMPR Newswire (US)Ameren's annual sustainability report focuses on ensuring reliability and supporting customersNYSE:AEEAmeren Corp
05/09/20246:08AMPR Newswire (US)Eastside Golf Enters Women's Market, Launches Women's Line
05/09/20246:07AMPR Newswire (US)800NK is the first ever CFMOTO to win the "Red Dot Award: Product Design"
05/09/20246:05AMPR Newswire (Canada)Rayonnement de Montréal à l'international - Pierre Lemonde tire sa révérence après presque 25 ans à la tête du CORIM
05/09/20246:05AMPR Newswire (Canada)Santé Canada approuve KEYTRUDA® pour le traitement, en association avec une chimiothérapie à base de gemcitabine, des adultes atteints d'un carcinome des voies biliaires non résécable localement avancé ou métastatiqueNYSE:MRKMerck and Co Inc
05/09/20246:05AMPR Newswire (Canada)Health Canada Approves KEYTRUDA® for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapyNYSE:MRKMerck and Co Inc
05/09/20246:05AMPR Newswire (Canada)Jay Cherrie Joins Boardwalktech's Advisory BoardTSXV:BWLKBoardwalktech Software Corp
05/09/20246:05AMPR Newswire (US)WARNER BROS. DISCOVERY REPORTS FIRST-QUARTER 2024 RESULTSNASDAQ:WBDWarner Brothers Discovery Inc
05/09/20246:05AMPR Newswire (Canada)Montreal's international outreach - Pierre Lemonde steps down as MCFR President and CEO after nearly 25 years
05/09/20246:02AMPR Newswire (US)Monster Energy's Matt Dawson Attempts to Set Record for Fastest Crossing of Mojave Desert on Foot -- Completely Solo and Unsupported
05/09/20246:02AMPR Newswire (Canada)L'INRS remettra trois doctorats honorifiques à des personnalités canadiennes influentes
05/09/20246:02AMPR Newswire (Canada)Argent de poche : les parents sont dans le flou, selon un rapport de MydohTSX:RYRoyal Bank of Canada
05/09/20246:02AMPR Newswire (Canada)INRS Awards Three Honorary Doctorates to Influential Canadian Figures
05/09/20246:02AMPR Newswire (Canada)Argent de poche : les parents sont dans le flou, selon un rapport de MydohNYSE:RYRoyal Bank of Canada
05/09/20246:01AMPR Newswire (Canada)Allowance uncertainty is real, according to Mydoh's Canadian Allowance ReportTSX:RYRoyal Bank of Canada
05/09/20246:01AMPR Newswire (US)World's Most Influential People in Ophthalmology
05/09/20246:01AMPR Newswire (Canada)Allowance uncertainty is real, according to Mydoh's Canadian Allowance ReportNYSE:RYRoyal Bank of Canada
05/09/20246:00AMPR Newswire (Canada)L'heure est au changement : les programmes de dépistage du cancer du sein doivent commencer dès l'âge de 40 ans
05/09/20246:00AMPR Newswire (Canada)AVIS AUX MÉDIAS - CASCADES PUBLIERA SES RÉSULTATS FINANCIERS DU PREMIER TRIMESTRE DE 2024 ET TIENDRA SON ASSEMBLÉE GÉNÉRALE ANNUELLE DES ACTIONNAIRES LE 9 MAITSX:CASCascades Inc
05/09/20246:00AMPR Newswire (Canada)Acquisition & Partenariat - Conversion d'un site commercial à Anjou vers un développement TOD de près de 1,000 unités résidentielles
05/09/20246:00AMPR Newswire (Canada)AVIS AUX MÉDIAS - Manifestation à HEC Montréal pour dénoncer le licenciement d'employés en voie de syndicalisation
05/09/20246:00AMPR Newswire (Canada)Pour un meilleur accès - Québec accélère l'augmentation du nombre d'admissions en médecine
05/09/20246:00AMPR Newswire (Canada)Aider sans filtre, pour et avec les jeunes - Un succès pour soutenir les jeunes proches aidants en santé mentale !
05/09/20246:00AMPR Newswire (Canada)/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Thursday, May 9, 2024/
05/09/20246:00AMPR Newswire (Canada)Action collective visant la SQDC
05/09/20246:00AMPR Newswire (Canada)/R E P E A T -- Media Advisory: Conference call for the release of the consolidated results of Quebecor Inc. for the first quarter 2024/TSX:QBR.AQuebecor Inc
05/09/20246:00AMPR Newswire (Canada)Medical Facilities Corporation Announces First Quarter Results and 11.8% Dividend IncreaseTSX:DRMedical Facilities Corporation
05/09/20246:00AMPR Newswire (Canada)Gold Flora Expands Cultivation Footprint at Desert Hot Springs Campus
05/09/20246:00AMPR Newswire (Canada)/R E P E A T -- Media Advisory: Conference call for the release of the consolidated results of Quebecor Inc. for the first quarter 2024/TSX:QBR.BQuebecor Inc

Your Recent History

USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
KGKG
Kona Gold Beverage (PK)
USOTC
FLES
Auto Parts 4Less (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
ILST
International Star (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
TKMO
Tekumo (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
BABL
Buildablock (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved